We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ask ADVFN Intelligence (AI)
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 PR Newswire WALTHAM, Mass., Oct. 14...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.13 | -3.77906976744 | 3.44 | 3.77 | 3.02 | 661964 | 3.35913924 | CS |
| 4 | -23.54 | -87.6722532588 | 26.85 | 28.66 | 3.02 | 709611 | 6.4197786 | CS |
| 12 | -41.58 | -92.6264201381 | 44.89 | 53.17 | 3.02 | 293762 | 14.29751724 | CS |
| 26 | -12.24 | -78.7138263666 | 15.55 | 53.79 | 3.02 | 198495 | 21.01936821 | CS |
| 52 | -12.93 | -79.618226601 | 16.24 | 53.79 | 3.02 | 149479 | 21.35556503 | CS |
| 156 | -12.93 | -79.618226601 | 16.24 | 53.79 | 3.02 | 149479 | 21.35556503 | CS |
| 260 | -12.93 | -79.618226601 | 16.24 | 53.79 | 3.02 | 149479 | 21.35556503 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
